Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful ...

Ampreloxetine is being developed to address the root cause of blood pressure instability in multiple system atrophy, aiming ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...

African Americans have been historically underrepresented in clinical trials, and California has taken steps to increase protections for research participants, while experts emphasize the importance ...

This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Iran – A new randomized clinical trial published in Dermatologic Therapy has found that intramuscular pantothenic acid ...

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number ...